Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Venous Thrombosis

Free Subscription Articles published in Circulation Retrieve available abstracts of 19 articles: HTML format

Single Articles

November 2021
1. NAEIJE R
   Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
   Circulation. 2021;144:e328-e329.
   PubMed    
   
   
   
2. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
   Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
   Circulation. 2021;144:e330-e331.
   PubMed    
   
   
   May 2021
3. ROBERT-EBADI H, Robin P, Hugli O, Verschuren F, et al
   Impact of the Age-Adjusted D-Dimer Cutoff to Exclude Pulmonary Embolism: A Multinational Prospective Real-Life Study (the RELAX-PE Study).
   Circulation. 2021;143:1828-1830.
   PubMed    
   
   
   April 2021
4. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
   Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
   Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
   PubMed     Abstract available
   
   
   March 2021
5. BUKHARI S, Barakat AF, Eisele YS, Nieves R, et al
   Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
   Circulation. 2021;143:1335-1337.
   PubMed    
   
   
   February 2021
6. 
   Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
   Circulation. 2021;143:e249.
   PubMed    
   
   
   November 2020
7. PACKARD CJ
   Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
   Circulation. 2020;142:e333-e334.
   PubMed    
   
   
   
8. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
   Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
   Circulation. 2020;142:e335-e336.
   PubMed    
   
   
   October 2020
9. MARSTON NA, Ruff CT, Sabatine MS
   Response by Marston et al to Letter Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
   Circulation. 2020;142:e264.
   PubMed    
   
   
   
10. QI Z, Sun A, Ge J
    Letter by Qi et al Regarding Article, "The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism".
    Circulation. 2020;142:e262-e263.
    PubMed    
    
    
    August 2020
11. CUSHMAN M, Barnes GD, Creager MA, Diaz JA, et al
    Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and Haemostasis.
    Circulation. 2020;142:e85-e94.
    PubMed     Abstract available
    
    
    July 2020
12. SPYROPOULOS AC, Weitz JI
    Hospitalized COVID-19 Patients and Venous Thromboembolism: A Perfect Storm.
    Circulation. 2020;142:129-132.
    PubMed    
    
    
    June 2020
13. 
    Correction to: Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2020;141:e932.
    PubMed    
    
    
    May 2020
14. HENKE PK, Kahn SR, Pannucci CJ, Secemksy EA, et al
    Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association.
    Circulation. 2020 May 7:CIR0000000000000769. doi: 10.1161/CIR.0000000000000769.
    PubMed     Abstract available
    
    
    April 2020
15. POISSY J, Goutay J, Caplan M, Parmentier E, et al
    Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence.
    Circulation. 2020 Apr 24. doi: 10.1161/CIRCULATIONAHA.120.047430.
    PubMed    
    
    
    March 2020
16. SCHWARTZ GG, Steg PG, Szarek M, Bittner VA, et al
    Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046524.
    PubMed     Abstract available
    
    
    
17. MARSTON NA, Gurmu Y, Melloni GEM, Bonaca M, et al
    The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046397.
    PubMed     Abstract available
    
    
    January 2020
18. GERGES C, Gerges M, Friewald R, Fesler P, et al
    Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment.
    Circulation. 2020 Jan 3. doi: 10.1161/CIRCULATIONAHA.119.041515.
    PubMed     Abstract available
    
    
    October 2019
19. GIRI J, Sista AK, Weinberg I, Kearon C, et al
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Oct 4:CIR0000000000000707. doi: 10.1161/CIR.0000000000000707.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: